The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)
Showing 1-20 of 33 articles
Quantitative flow ratio versus fractional flow reserve for guiding percutaneous coronary intervention: design and rationale of the randomised FAVOR III Europe Japan trial
Andersen B,
Sejr-Hansen M,
Westra J,
Campo G,
Eftekhari A,
Tu S,
Escaned J,
Koltowski L,
Stähli B,
Erglis A,
Jaruševičius G,
Žiubrytė G,
Råmunddal T,
Liu T,
Wijns W,
Landmesser U,
Maillard L,
Matsuo H,
Christiansen E,
Holm N
April 3, 2023 | 10.4244/EIJ-D-21-00214
Prognostic value of structural and functional coronary microvascular dysfunction in patients with non-obstructive coronary artery disease; from the multicentre international ILIAS registry
Boerhout C,
de Waard G,
Lee JM,
Mejía-Rentería H,
Lee SH,
Jung J,
Hoshino M,
Echavarria-Pinto M,
Meuwissen M,
Matsuo H,
Madera-Cambero M,
Eftekhari A,
Effat M,
Murai T,
Marques K,
Appelman Y,
Doh J,
Christiansen E,
Banerjee R,
Nam C,
Niccoli G,
Nakayama M,
Tanaka N,
Shin E,
Beijk M,
Knaapen P,
Escaned J,
Kakuta T,
Koo B,
Piek J,
van de Hoef TP
October 21, 2022 | 10.4244/EIJ-D-22-00043
Polymer-free biolimus-coated stents versus ultrathin-strut biodegradable polymer sirolimus-eluting stents: two-year outcomes of the randomised SORT OUT IX trial
Ellert-Gregersen J,
Jensen L,
Jakobsen L,
Freeman PM,
Eftekhari A,
Maeng M,
Raungaard B,
Engstroem T,
Kahlert J,
Hansen H,
Christiansen E
June 3, 2022 | 10.4244/EIJ-D-21-00874
Clinical outcomes of everolimus-eluting bioresorbable scaffolds or everolimus-eluting stents in patients with acute myocardial infarction: two-year results of the randomised ISAR-Absorb MI trial
Wiebe J,
Byrne RA,
Alfonso F,
Maeng M,
Bradaric C,
Kretov E,
Cuesta J,
Kuna C,
Ibrahim T,
Rivero F,
Heugl M,
Christiansen E,
Joner M,
Schunkert H,
Laugwitz K,
Kastrati A,
Cassese S
March 18, 2022 | 10.4244/EIJ-D-21-00653
Reproducibility of quantitative flow ratio: the QREP study
Westra J,
Sejr-Hansen M,
Koltowski L,
Mejía-Rentería H,
Tu S,
Kochman J,
Zhang Y,
Liu T,
Campo G,
Hjort J,
Mogensen LJH,
Erriquez A,
Andersen B,
Eftekhari A,
Escaned J,
Christiansen E,
Holm N
February 18, 2022 | 10.4244/EIJ-D-21-00425
Membranous septum morphology and risk of conduction abnormalities after transcatheter aortic valve implantation
Jørgensen T,
Hansson N,
De Backer O,
Bieliauskas G,
Terkelsen CJ,
Wang X,
Jensen J,
Christiansen E,
Piazza N,
Svendsen J,
Nørgaard B,
Søndergaard L
January 28, 2022 | 10.4244/EIJ-D-21-00363
One-step anatomic and function testing by cardiac CT versus second-line functional testing in symptomatic patients with coronary artery stenosis: head-to-head comparison of CT-derived fractional flow reserve and myocardial perfusion imaging
Westra J,
Li Z,
Rasmussen L,
Winther S,
Li G,
Nissen L,
Petersen S,
Ejlersen J,
Isaksen C,
Gormsen L,
Urbonaviciene G,
Eftekhari A,
Weng T,
Qu X,
Bøtker H,
Christiansen E,
Holm N,
Bøttcher M,
Tu S
September 20, 2021 | 10.4244/EIJ-D-20-00905
Intravascular ultrasound to guide left main stem intervention: a NOBLE trial substudy
Ladwiniec A,
Walsh S,
Holm N,
Hanratty C,
Mäkikallio T,
Kellerth T,
Hildick-Smith D,
Mogensen L,
Hartikainen J,
Menown I,
Erglis A,
Eriksen E,
Spence M,
Thuesen L,
Christiansen E
June 25, 2020 | 10.4244/EIJ-D-19-01003
Safety and performance of the second-generation drug-eluting absorbable metal scaffold (DREAMS 2G) in patients with de novo coronary lesions: three-year clinical results and angiographic findings of the BIOSOLVE-II first-in-man trial
Haude M,
Ince H,
Toelg R,
Lemos P,
von Birgelen C,
Christiansen E,
Wijns W,
Neumann F,
Eeckhout E,
Garcia-Garcia H,
Waksman R
February 7, 2020 | 10.4244/EIJ-D-18-01000
Three-year follow-up of the randomised comparison between an everolimus-eluting bioresorbable scaffold and a durable polymer everolimus-eluting metallic stent in patients with ST-segment elevation myocardial infarction (TROFI II trial)
Katagiri Y,
Onuma Y,
Asano T,
Iñiguez A,
Jensen L,
Cequier A,
Hofma S,
Christiansen E,
Suttorp M,
Brugaletta S,
Räber L,
Sabaté M,
Windecker S,
Serruys P
December 7, 2018 | 10.4244/EIJ-D-18-00839
Intravascular ultrasound findings of the Fantom sirolimus-eluting bioresorbable scaffold at six- and nine-month follow-up: the FANTOM II study
van Zandvoort L,
Dudek D,
Weber-Albers J,
Abizaid A,
Christiansen E,
Muller DW,
Kochman J,
Kołtowski Ł,
Lassen JF,
Wojdyla R,
Wykrzykowska JJ,
Onuma Y,
Daemen J
December 7, 2018 | 10.4244/EIJ-D-18-00491
Ten-year clinical outcome of patients treated with a drug-eluting stent in the proximal left anterior descending artery segment compared with patients stented in other non-left main coronary segments
Kjoller-Hansen L,
Bligaard N,
Kelbæk H,
Christiansen E,
Thuesen L,
Hansen PR,
Engstrøm T,
Junker A,
Abildgaard U,
Lassen JF,
Jensen JS,
Jeppesen JL,
Galloe A
September 20, 2018 | 10.4244/EIJ-D-18-00396
Keep bifurcation stenting simple and cheap or controlled and optimised?
February 2, 2018 | 10.4244/EIJV13I15A282
Final five-year outcomes after implantation of biodegradable polymer-coated biolimus-eluting stents versus durable polymer-coated sirolimus-eluting stents
Jakobsen L,
Christiansen E,
Maeng M,
Hansen K,
Kristensen SD,
Bøtker H,
Terkelsen CJ,
Jensen SE,
Raungaard B,
Madsen M,
Lassen JF,
Jensen L
December 20, 2017 | 10.4244/EIJ-D-17-00434
Sustained safety and clinical performance of a drug-eluting absorbable metal scaffold up to 24 months: pooled outcomes of BIOSOLVE-II and BIOSOLVE-III
Haude M,
Ince H,
Kische S,
Abizaid A,
Toelg R,
Lemos P,
Van Mieghem NM,
Verheye S,
von Birgelen C,
Christiansen E,
Wijns W,
Garcia-Garcia H,
Waksman R
July 20, 2017 | 10.4244/EIJ-D-17-00254
The first clinical experience with a novel “locking” microcatheter in chronic coronary total occlusions
Wilson S,
Maeramans J,
Walsh S,
Hanratty C,
Meyer-Gessner M,
Dens J,
Christiansen E,
Bufe A,
Spratt J
February 3, 2017 | 10.4244/EIJ-D-16-00272
Arterial healing following primary PCI using the Absorb everolimus-eluting bioresorbable vascular scaffold (Absorb BVS) versus the durable polymer everolimus-eluting metallic stent (XIENCE) in patients with acute ST-elevation myocardial infarction: rationale and design of the randomised TROFI II study
Räber L,
Onuma Y,
Brugaletta S,
Garcia-Garcia H,
Backx B,
Iñiguez A,
Jensen L,
Cequier-Fillat A,
Pilgrim T,
Christiansen E,
Hofma S,
Suttorp M,
Serruys P,
Sabaté M,
Windecker S
July 20, 2016 | 10.4244/EIJY15M08_03
Latest news
AHEAD OF PRINT
Robotic-assisted CABG: clinical outcomes
FREE ARTICLE - Aleksander Dokollari et al
November 23, 2023
PCR London Valves 2023
November 16, 2023
NEW ISSUE
PCR London Valves special edition. State-of-the-art on TMVI; the timing of TMVI; direct wire pacing for TMVR; predicting patient-prosthesis mismatch following TAVI and more
November 17, 2023
AHEAD OF PRINT
Pathophysiological CAD patterns predict outcomes post-PCI
FREE ARTICLE - Nozomi Kotoku et al
November 14, 2023
AHEAD OF PRINT
Extra-mitral valve cardiac involvement in MR
FREE ARTICLE - Antonio Popolo Rubbio et al
November 9, 2023
AHEAD OF PRINT
Cardiac damage classification in each AS subtype
FREE ARTICLE - Masaaki Nakase et al
November 6, 2023
AHEAD OF PRINT
CAPTIS embolic protection during TAVR
FREE ARTICLE - Haim D. Danenberg et al
November 2, 2023